Clinical Trials Browser

Observational × aldesleukin × Genitourinary × Clear all

NCT00617799 2023-10-10

Biomarkers That Predict Response to High-Dose Aldesleukin in Metastatic Kidney Cancer or Metastatic Melanoma

DermatologicGenitourinary

Carcinoma, Renal Cell, Kidney Neoplasms, Melanoma